Isomorphic Labs, Alphabet's AI-driven drug discovery company, is negotiating a funding round of approximately $5 billion that would value the firm at around $50 billion. The talks are not yet finalized, and details remain subject to change.
Spun out of Google DeepMind in 2021, Isomorphic Labs leverages the AlphaFold protein structure prediction model for drug discovery. In May 2026, the company closed a $2.1 billion round led by Thrive Capital with participation from Alphabet and other investors.
Alphabet's Isomorphic Labs in Talks to Raise ~$5 Billion at $50 Billion Valuation
Avertissement : Le contenu proposé sur Phemex News est à titre informatif uniquement. Nous ne garantissons pas la qualité, l'exactitude ou l'exhaustivité des informations provenant d'articles tiers. Ce contenu ne constitue pas un conseil financier ou d'investissement. Nous vous recommandons vivement d'effectuer vos propres recherches et de consulter un conseiller financier qualifié avant toute décision d'investissement.